Melanoma Brain Metastases and Vemurafenib: Need for Further Investigation

submitted by: WentzMR
Dr. Roxana Dronca, a Medical Oncologist, Senior Associate Consultant, and Assistant Professor of Oncology at Mayo Clinic in Rochester, MN, discusses her article appearing in the October 2012 issue of Mayo Clinic Proceedings where she confirms the need for continued vigilance for brain metastases in patients with BRAF mutated metastatic melanoma, despite simultaneous successful response of extracranial metastases to BRAF-targeted therapy with vemurafenib. Available at:...

The High Cost of Cancer Drugs and What We Can do About it.

submitted by: WentzMR
Dr. S. Vincent Rajkumar, a Hematologist from Mayo Clinic in Rochester, MN, discusses his article appearing in the October 2012 issue of Mayo Clinic Proceedings, where he explains the reasons behind the high cost of cancer treatments in the US and provides several considerations for reducing these expenses. Available at: http://www.mayoclinicproceedings.org/article/S0025-6196(12)00738-0/fulltext Visit the Mayo Clinic Proceedings website: www.MayoClinicProceedings.org Find more videos:...

The High Cost of Cancer Drugs and What We Can do About it.

submitted by: WentzMR
Dr. Mustaqeem Siddiqui, a Hospitalist in Hematology and Oncology at Mayo Clinic in Rochester, MN, introduces his article appearing in the October 2012 issue of Mayo Clinic Proceedings on the high cost of cancer treatments. Available at: http://www.mayoclinicproceedings.org/article/ S0025-6196(12)00738-0/fulltext Visit the Mayo Clinic Proceedings website: www.MayoClinicProceedings.org Find more videos: www.YouTube.com/MayoProceedings Follow us on Twitter:...

Antiepileptic Drugs 2012: Recent Advances and Trends.

submitted by: WentzMR

Dr. Joseph Sirven, Professor of Neurology from Mayo Clinic in Phoenix, AZ, reviews his article appearing in the September 2012 issue of Mayo Clinic Proceedings, where he discusses 25 newly approved medications and 3 trends to aid in making the best clinical decisions for patients with epilepsy.
Available at: http://www.mayoclinicproceedings.org/article/S0025-6196(12)00678-7/fulltext

The Toxic Effects of Cigarette Additives. Philip Morris' Project Mix Reconsidered: An Analysis of Documents Released through Lit

submitted by: glantz
This video describes the peer reviewed paper, Wertz MS, Kyriss T, Paranjape S, Glantz SA (2011) The Toxic Effects of Cigarette Additives. Philip Morris' Project Mix Reconsidered: An Analysis of Documents Released through Litigation. PLoS Med 8(12): e1001145. doi:10.1371/journal.pmed.1001145 Background In 2009, the promulgation of US Food and Drug Administration (FDA) tobacco regulation focused attention on cigarette flavor additives. The tobacco industry had prepared for this...

Pain Management in the Cirrhotic Patient: The Clinical Challenge.

submitted by: mcgheekkm

Expert Opinion for Pain Management in Cirrhotic Patients--Mayo Clinic article published in Mayo Clinic Proceedings.